Launch of Propofol Injectable Emulsion, USP in the U.S. Market Announced by Avenacy
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, announced it has launched Propofol Injectable Emulsion, USP in the United States as a therapeutic generic equivalent for Diprivan® as approved by the U.S. Food and Drug Administration.